Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

StartEngine Review: ‘Mr. Wonderful’ Approves This Crowdfunding Platform

By Dana Blankenhorn, InvestorPlace Contributor

My StartEngine review concludes that thanks to the endorsement of "Mr. Wonderful," this equity crowdfunding platform is a true star.

Is Inovio Pharmaceuticals Really Just the Next Theranos?

By Dana Blankenhorn, InvestorPlace Contributor

Even scientists are still guessing whether any Covid-19 treatment or vaccine works. Inovio's INO-4800 might work, but we won't know for about a year.

Zoom Stock Is Still Worth Holding After Becoming a Household Name

By Dana Blankenhorn, InvestorPlace Contributor

Zoom has gotten so big its name is now considered a verb for videoconferencing. That gives Zoom stock a shot against scaled competitors.

Twitter Stock Is Caught Between a Rock and a Hard Place

By Dana Blankenhorn, InvestorPlace Contributor

Trump's attack on social media raises questions about Twitter's business model, as well as politics. Buy Square instead of Twitter stock.

Why Moderna Stock Is Still Only Good for Speculators

By Dana Blankenhorn, InvestorPlace Contributor

Moderna has become the stock market's great hope for a Covid-19 vaccine, but there are dozens of other candidates.

Load More